CMS Entry id: 2709 | Channel: Blog landing page | Template: blog/index

Login
Facebook YouTube Twitter Linkedin
Facebook YouTube Twitter Linkedin

Blog

CANTAB tests predict functional decline in patients with amnestic mild cognitive impairment

We presented a novel, predictive model of functional decline at CTAD 2018. The model suggests that CANTAB PAL and SWM provide essential screening information when recruiting patients with amnestic mild cognitive impairment into Alzheimer’s disease clinical trials.

web-based testing, wearables, voice recognition, virtual clinical trials, unit, technology, swm, subjective measures, stigma, social cognition, smartphones, schizotypal disorder, schizophrenia research, schizophrenia, research funding, research, remote testing, regulations, recruitment, prodromal, pro-cognitive, presenteeism, precision psychiatry, pre-clinical, poster, personalised medicine, patient-centric, patient recruitment, parkinson's disease, pal, paired associates learning, ots, online, occupational health, objective measures, normative data, neurotech, neuroscience, near-patient testing, multiple sclerosis, ms, modelling, mental wellbeing, mental health at work, mental health, mdd, mci, major depression, ied, hot cognition, high frequency, healthcare, guide, funding, expert witness, ert, epidemiology, emotion recognition, ebt, ebbinghaus, early career researchers, early alzheimer's disease, drug development, digital tools, digital health, depression, dementia, cognitive wellbeing, cognitive testing, cognitive science, cognitive safety, cognitive research, cognitive impairment, cognitive function, cognitive dysfunction, cognitive deficits, cognitive biomarkers, cognitive assessment, cognition kit, cognition, cns summit, clinical trials, clinical trial, cias, cgt, cantab testimonial, cantab research grant, cantab for clinical trials, cantab, brain health, biomarkers, awards, automatic speech recognition, autism, attention, asd, alzheimer's disease, affective cognition, adolescents, absenteeism,